Skip to content

RELAXaHEAD for Headache Patients (Phase I)

RELAXaHEAD for Headache Patients (Phase I)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03183791
Enrollment
402
Registered
2017-06-12
Start date
2017-11-01
Completion date
2019-05-25
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine, Multiple Sclerosis

Brief summary

The goal of this research is to assess the utility of smartphone-based progressive muscle relaxation (PMR) for the treatment of headaches. While there are many commercially available electronic diary and mind-body intervention apps for headache, there is little data showing their efficacy. RELAXaHEAD app incorporates the electronic PMR that was successfully used in an earlier epilepsy study and beta tested with headache specialist and migraine patient input. It also is an electric headache diary. This 2-arm randomized controlled study will evaluate the feasibility and acceptability of RELAX for use with headache patients. One arm will be the RELAX group (the RELAXaHEAD app) and the other arm will be a monitored usual care (MUC) group (this group receives standard of care and uses the electronic daily symptom reporting diary). The goals are to assess the feasibility and adherence of the RELAX intervention in persons with headache (Aim 1) and to gather exploratory data on the effects of the RELAX intervention on headache related outcome measures (Aim 2).

Interventions

The Research Volunteers (RV) will load the app onto the patients' smartphones but the PMR component will be blocked on the version of the app that the MUC patients receive. Subjects will be taught to enter their headache log daily on the app.

BEHAVIORALRELAXaHEAD app

The Research Volunteers (RV) will explain the rationale for PMR and load the RELAXaHEAD app onto the patients' smartphones. The RV will review the app with the subject, focusing on user knowledge, usability, and engagement. The patient will perform a 15 minute session of PMR during the study enrollment and discuss the optimal time and place to practice PMR at home. Subjects will also be taught to enter their headache log daily on the app.

Sponsors

National Multiple Sclerosis Society
CollaboratorOTHER
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Meets migraine criteria based on International Classification of Headache Disorders (ICHD) 3 beta (based on questions in RedCap * 4 or more headache days per month

Exclusion criteria

* Patients who have had Cognitive Behavioral Therapy, Biofeedback or other Relaxation Therapy for Migraine in the past year * Cognitive deficit or other physical problem with the potential to interfere with behavioral therapy * Alcohol or other substance abuse as determined by self-report or prior documentation in the medical record * Opioid or barbiturate use 10+ days a month * Unable or unwilling to follow a treatment program that relies on written and audio recorded materials * Not having a smartphone

Design outcomes

Primary

MeasureTime frameDescription
Number of days spent logging headache data as determined by entries into the RELAXaHEAD app90 DaysMeasure of feasibility
Number of days spent doing PMR as determined with the backend analytics in the RELAXaHEAD app backend analytics in the RELAXaHEAD app90 DaysMeasure of feasibility
Minutes/day spent doing PMR as determined with the backend analytics in the RELAXaHEAD app90 DaysMeasure of feasibility
Satisfaction using Likert scale questions on RELAXaHEAD usability, content, and functionalityBaselineMeasure of acceptability

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026